REGENXBIO Inc. (NASDAQ:RGNX) has earned a consensus rating of “Buy” from the eleven research firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating on the company. The average 12-month price target among […]
